Literature DB >> 15565604

AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings.

Morris Sherman1, Andrew Klein.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15565604     DOI： 10.1002/hep.20528

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  17 in total

1.  Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.

Authors:  Hatem A El-mezayen; Hossam Darwish
Journal:  Tumour Biol       Date:  2014-04-01

2.  Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial.

Authors:  Takamasa Ohki; Ryosuke Tateishi; Masaaki Akahane; Shuichiro Shiina; Noriyo Yamashiki; Shintaro Mikami; Kenichiro Enooku; Eriko Goto; Ryota Masuzaki; Yuji Kondo; Tadashi Goto; Shinichi Inoo; Kuni Ohtomo; Masao Omata; Haruhiko Yoshida; Kazuhiko Koike
Journal:  Hepatol Int       Date:  2011-08-31       Impact factor: 6.047

3.  Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.

Authors:  Jiang Jingting; Wu Changping; Xu Ning; Zhu yibei; Wu Jun; Ji Mei; Xu Bin; Nilsson-Ehle Peter; Zhang Xueguan
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 4.  Targeted therapy for hepatocellular carcinoma.

Authors:  Hans Christian Spangenberg; Robert Thimme; Hubert E Blum
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06-02       Impact factor: 46.802

Review 5.  Liver cirrhosis.

Authors:  Detlef Schuppan; Nezam H Afdhal
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

Review 6.  Acute Kidney Injury in Patients with Cirrhosis.

Authors:  Kirk B Russ; Todd M Stevens; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

7.  CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.

Authors:  Takamasa Ohki; Ryosuke Tateishi; Masaaki Akahane; Shintaro Mikami; Masaya Sato; Koji Uchino; Toru Arano; Kenichiro Enooku; Yuji Kondo; Noriyo Yamashiki; Tadashi Goto; Shuichiro Shiina; Haruhiko Yoshida; Yutaka Matsuyama; Masao Omata; Kuni Ohtomo; Kazuhiko Koike
Journal:  Am J Gastroenterol       Date:  2013-04-30       Impact factor: 10.864

8.  Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.

Authors:  Yuqing Mao; Shaoren Zhang; Fujun Yu; Huanqing Li; Chuanyong Guo; Xiaoming Fan
Journal:  Int J Mol Sci       Date:  2015-09-10       Impact factor: 5.923

9.  Evolving therapies in the treatment of hepatocellular carcinoma.

Authors:  Hans Christian Spangenberg; Robert Thimme; Hubert E Blum
Journal:  Biologics       Date:  2008-09

10.  Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.

Authors:  Jae-Woo Jang; Yeonhwa Song; Kang Mo Kim; Jin-Sun Kim; Eun Kyung Choi; Joon Kim; Haengran Seo
Journal:  BMC Cancer       Date:  2016-10-18       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.